CLIA-88Clinical Laboratory Improvement Amendments of 1988
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Neither the CLIA-88 nor the external quality assessment systems have absolute limits for evaluation of trueness.
Using the criteria established under CLIA-88 to evaluate clinically significant interference, we investigated four analytes measured on the Hitachi 747 for interference caused by the presence of DCLHb.
Plotting the DCLHb concentration and apparent analyte concentration obtained from the specimen on the interference plot enables one to determine if the measured analyte result can be reported and be within the limits specified under the CLIA-88 rules for clinically significant bias.